The Public Health Agency (PHA) has been made aware that there is likely to be a delay in the supply of some of the Fluenz Tetra children’s vaccine due to arrive next month. The vaccine is procured by Public Health England on behalf of all of the UK. The delay is due to issues relating to routine testing of the Fluenz Tetra nasal flu vaccine by the manufacturer and is not related to the safety or the efficacy of the vaccine. Work is under way to minimise potential disruption to the childhood flu immunisation programme in Northern Ireland caused by this. In line with the rest of the UK the Chief

The need to put strong partnership working at the centre of public health is the central focus of the Director of Public Health’s Annual Report, published today. Speaking at the launch in Bellaghy, Dr Adrian Mairs, Acting Director of Public Health at the Public Health Agency (PHA), said: “One of the key challenges facing us as a society is health inequality. This is a complex issue that involves many different and interwoven factors, including childhood development, deprivation, the social and physical environment, and education. This means the response needs to be collaborative and results

The Public Health Agency (PHA) has funded Extern to commence a pilot project of a community-based needle exchange service, helping to meet the needs of people who inject. Those who previously used the Boots Needle and Syringe Exchange Scheme (NSES) service will continue to have full access to needle exchange services in Belfast city centre Along with the new community-based pilot project, they will be redirected to other needle exchange community pharmacies in the city centre, and for clients with more complex needs, community-based service providers, including the Belfast Drug Outreach team

Claragh Gibney, a year 9 pupil at St Colman’s, Ballynahinch was diagnosed three years ago with type 1 diabetes after her mum Teresa took her to her GP after noticing a number of symptoms. Type 1 diabetes cannot be prevented and occurs when the pancreas is no longer able to produce insulin. It is the most common type of diabetes in children and young adults. Claragh’s mum Teresa explains: “She was a perfectly healthy nine year old. She went to school and attended dance classes; it wasn’t until we went on holidays that she started to get sick. “We noticed her asking for drinks – water, juice or

On Friday 11th October a networking event was held in Seagoe Parish Centre, Portadown. The Public Health Agency (PHA), Southern Health & Social Care Trust, Councils (Armagh Banbridge Craigavon, Newry Mourne and Down and Mid Ulster) and the Protect Life Community & Voluntary Forum came together to organise and participate in the promotional event. The aim of the event was to provide an opportunity for those working to promote positive mental health in the Southern area to raise awareness of the various services available in their locality and connect and support eachother. Participants heard

Experts from across Europe will meet in Belfast this week to discuss collaboration and development in an innovative area of healthcare known as personalised medicine. Personalised medicine aims to shift treatment from a ‘one size fits all’ approach to one which targets treatments and therapies to the individual needs of each patient, securing better outcomes and more effective prevention. Dr Michael McBride, Chief Medical Officer, said: “Here in Northern Ireland, personalised medicine is an area of substantial and rapidly increasing focus. A growing population with a higher number of older

Researchers from Queen’s University Belfast have discovered a new way to predict the aggressiveness and future behaviour of prostate cancers. The research was supported by the Belfast-Manchester Movember Centre of Excellence, Prostate Cancer UK, and the Health and Social Care Research and Development Division of the Public Health Agency. The new method uses images from computed tomography (CT) scans that are routinely collected from all patients. The images are then analysed by a computer to extract hundreds of features, termed ‘radiomic features’, which have the potential to uncover disease

Researchers from both sides of the Irish border have joined together in a large trial that looks at whether an inexpensive medication, already used to treat other conditions, could help prevent those who have already had a stroke from having a further stroke. The CONVINCE study – which is currently taking place in nine centres across Europe – has been extended to include centres in Northern Ireland and the border counties of the Republic of Ireland. The extension follows a funding boost of just over €600,000 by the Public Health Agency in Northern Ireland, the Stroke Association, and the